{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-25-001899","form_type":"8-K","ticker":"IRD","cik":"0001228627","company_name":"Opus Genetics, Inc.","filed_at":"2025-01-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:03.132676+00:00","generated_at":"2026-05-27T10:28:01.326185+00:00","sec_items":["5.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Opus Genetics amends CEO and CFO employment agreements; enhances severance upon Change in Control","bullets":["CEO Magrath severance multiple raised to 1.5x salary+target bonus on CIC termination; COBRA extended to 18 months.","CFO Jhaveri severance multiple raised to 1.0x salary+target bonus; COBRA extended to 12 months.","Magrath also gets prorated target bonus for non-CIC qualifying termination.","Jhaveri's enhanced sever eligibility expanded to include 3 months prior to a Change in Control."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-25-001899","json":"https://secwatch.observer/filing/0001140361-25-001899.json","markdown":"https://secwatch.observer/filing/0001140361-25-001899.md","text":"https://secwatch.observer/filing/0001140361-25-001899.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125001899/0001140361-25-001899-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1228627/000114036125001899/ef20042243_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-27T10:28:01.326185+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}